Risk of Cytomegalovirus Reactivation in Patients With Immune-Mediated Inflammatory Diseases Undergoing Biologic Treatment: A Real Matter?. Reumatismo 2016, 68 (3), 144-147. https://doi.org/10.4081/reumatismo.2016.897.